Form 4 for MDT Medtronic

Accepted 2023-08-02 00:00:00 ET · period of report 2023-07-31 · accession 0001613103-23-000068 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-08-02	2023-07-31	MDT	Martha Geoffrey	COB, CEO, Dir	A - Grant	$0.00	+34.2K	139.1K	+33%	$0
DM	2023-08-02	2023-07-31	MDT	Martha Geoffrey	COB, CEO, Dir	A - Grant	$0.00	+326.2K	481.4K	+210%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Ordinary Shares	2023-07-31	A	A	34,185	$0.00	139,097	D	—	—	(F1) The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. (F2) Includes 2,415 units acquired through dividend reinvestment since the last report filed by the reporting person.
2	Derivative	Performance Share Units	2023-07-31	A	A	85,461	$0.00	85,461	D	— · — to —	85,461 Performance Share Units	(F4) The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 85,461 shares will be issued. If maximum performance metrics are achieved, 170,922 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. (F3) Each performance share unit represents a contingent right to receive one share of Medtronic common stock. (F5) Vests on July 31, 2026.
3	Derivative	Stock Option (Right to Buy)	2023-07-31	A	A	240,691	$0.00	481,382	D	$87.76 · — to 2033-07-31	240,691 Ordinary Shares	(F6) These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant.